Global Cancer (Tumor) Profiling Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Cancer (Tumor) Profiling Revenue
• 1.4 Market by Type
  • 1.4.1 Global Cancer (Tumor) Profiling Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Immunoassay
  • 1.4.3 Hybridization
  • 1.4.4 NGS
  • 1.4.5 Mass Spectrometry
• 1.5 Market by Application
  • 1.5.1 Global Cancer (Tumor) Profiling Market Share by Application: 2020 VS 2026
  • 1.5.2 Clinical
  • 1.5.3 Research
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Cancer (Tumor) Profiling Market Perspective (2015-2026)
• 2.2 Global Cancer (Tumor) Profiling Growth Trends by Regions
  • 2.2.1 Cancer (Tumor) Profiling Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Cancer (Tumor) Profiling Historic Market Share by Regions (2015-2020)
  • 2.2.3 Cancer (Tumor) Profiling Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Cancer (Tumor) Profiling Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Cancer (Tumor) Profiling Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Cancer (Tumor) Profiling Players by Market Size
  • 3.1.1 Global Top Cancer (Tumor) Profiling Players by Revenue (2015-2020)
  • 3.1.2 Global Cancer (Tumor) Profiling Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Cancer (Tumor) Profiling Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Cancer (Tumor) Profiling Market Concentration Ratio
  • 3.2.1 Global Cancer (Tumor) Profiling Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Cancer (Tumor) Profiling Revenue in 2019
• 3.3 Cancer (Tumor) Profiling Key Players Head office and Area Served
• 3.4 Key Players Cancer (Tumor) Profiling Product Solution and Service
• 3.5 Date of Enter into Cancer (Tumor) Profiling Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Cancer (Tumor) Profiling Historic Market Size by Type (2015-2020)
• 4.2 Global Cancer (Tumor) Profiling Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Cancer (Tumor) Profiling Market Size by Application (2015-2020)
• 5.2 Global Cancer (Tumor) Profiling Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Cancer (Tumor) Profiling Market Size (2015-2020)
• 6.2 Cancer (Tumor) Profiling Key Players in North America (2019-2020)
• 6.3 North America Cancer (Tumor) Profiling Market Size by Type (2015-2020)
• 6.4 North America Cancer (Tumor) Profiling Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Cancer (Tumor) Profiling Market Size (2015-2020)
• 7.2 Cancer (Tumor) Profiling Key Players in Europe (2019-2020)
• 7.3 Europe Cancer (Tumor) Profiling Market Size by Type (2015-2020)
• 7.4 Europe Cancer (Tumor) Profiling Market Size by Application (2015-2020)

8 China

• 8.1 China Cancer (Tumor) Profiling Market Size (2015-2020)
• 8.2 Cancer (Tumor) Profiling Key Players in China (2019-2020)
• 8.3 China Cancer (Tumor) Profiling Market Size by Type (2015-2020)
• 8.4 China Cancer (Tumor) Profiling Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Cancer (Tumor) Profiling Market Size (2015-2020)
• 9.2 Cancer (Tumor) Profiling Key Players in Japan (2019-2020)
• 9.3 Japan Cancer (Tumor) Profiling Market Size by Type (2015-2020)
• 9.4 Japan Cancer (Tumor) Profiling Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Cancer (Tumor) Profiling Market Size (2015-2020)
• 10.2 Cancer (Tumor) Profiling Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Cancer (Tumor) Profiling Market Size by Type (2015-2020)
• 10.4 Southeast Asia Cancer (Tumor) Profiling Market Size by Application (2015-2020)

11 India

• 11.1 India Cancer (Tumor) Profiling Market Size (2015-2020)
• 11.2 Cancer (Tumor) Profiling Key Players in India (2019-2020)
• 11.3 India Cancer (Tumor) Profiling Market Size by Type (2015-2020)
• 11.4 India Cancer (Tumor) Profiling Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Cancer (Tumor) Profiling Market Size (2015-2020)
• 12.2 Cancer (Tumor) Profiling Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Cancer (Tumor) Profiling Market Size by Type (2015-2020)
• 12.4 Central & South America Cancer (Tumor) Profiling Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Illumina
  • 13.1.1 Illumina Company Details
  • 13.1.2 Illumina Business Overview
  • 13.1.3 Illumina Cancer (Tumor) Profiling Introduction
  • 13.1.4 Illumina Revenue in Cancer (Tumor) Profiling Business (2015-2020))
  • 13.1.5 Illumina Recent Development
• 13.2 Qiagen
  • 13.2.1 Qiagen Company Details
  • 13.2.2 Qiagen Business Overview
  • 13.2.3 Qiagen Cancer (Tumor) Profiling Introduction
  • 13.2.4 Qiagen Revenue in Cancer (Tumor) Profiling Business (2015-2020)
  • 13.2.5 Qiagen Recent Development
• 13.3 Neogenomics Laboratories
  • 13.3.1 Neogenomics Laboratories Company Details
  • 13.3.2 Neogenomics Laboratories Business Overview
  • 13.3.3 Neogenomics Laboratories Cancer (Tumor) Profiling Introduction
  • 13.3.4 Neogenomics Laboratories Revenue in Cancer (Tumor) Profiling Business (2015-2020)
  • 13.3.5 Neogenomics Laboratories Recent Development
• 13.4 HTG Molecular Diagnostics
  • 13.4.1 HTG Molecular Diagnostics Company Details
  • 13.4.2 HTG Molecular Diagnostics Business Overview
  • 13.4.3 HTG Molecular Diagnostics Cancer (Tumor) Profiling Introduction
  • 13.4.4 HTG Molecular Diagnostics Revenue in Cancer (Tumor) Profiling Business (2015-2020)
  • 13.4.5 HTG Molecular Diagnostics Recent Development
• 13.5 Genomic Health
  • 13.5.1 Genomic Health Company Details
  • 13.5.2 Genomic Health Business Overview
  • 13.5.3 Genomic Health Cancer (Tumor) Profiling Introduction
  • 13.5.4 Genomic Health Revenue in Cancer (Tumor) Profiling Business (2015-2020)
  • 13.5.5 Genomic Health Recent Development
• 13.6 Caris Life Sciences
  • 13.6.1 Caris Life Sciences Company Details
  • 13.6.2 Caris Life Sciences Business Overview
  • 13.6.3 Caris Life Sciences Cancer (Tumor) Profiling Introduction
  • 13.6.4 Caris Life Sciences Revenue in Cancer (Tumor) Profiling Business (2015-2020)
  • 13.6.5 Caris Life Sciences Recent Development
• 13.7 Helomics Corporation
  • 13.7.1 Helomics Corporation Company Details
  • 13.7.2 Helomics Corporation Business Overview
  • 13.7.3 Helomics Corporation Cancer (Tumor) Profiling Introduction
  • 13.7.4 Helomics Corporation Revenue in Cancer (Tumor) Profiling Business (2015-2020)
  • 13.7.5 Helomics Corporation Recent Development
• 13.8 Nanostring Technologies
  • 13.8.1 Nanostring Technologies Company Details
  • 13.8.2 Nanostring Technologies Business Overview
  • 13.8.3 Nanostring Technologies Cancer (Tumor) Profiling Introduction
  • 13.8.4 Nanostring Technologies Revenue in Cancer (Tumor) Profiling Business (2015-2020)
  • 13.8.5 Nanostring Technologies Recent Development
• 13.9 Oxford Gene Technology
  • 13.9.1 Oxford Gene Technology Company Details
  • 13.9.2 Oxford Gene Technology Business Overview
  • 13.9.3 Oxford Gene Technology Cancer (Tumor) Profiling Introduction
  • 13.9.4 Oxford Gene Technology Revenue in Cancer (Tumor) Profiling Business (2015-2020)
  • 13.9.5 Oxford Gene Technology Recent Development
• 13.10 Ribomed Biotechnologies
  • 13.10.1 Ribomed Biotechnologies Company Details
  • 13.10.2 Ribomed Biotechnologies Business Overview
  • 13.10.3 Ribomed Biotechnologies Cancer (Tumor) Profiling Introduction
  • 13.10.4 Ribomed Biotechnologies Revenue in Cancer (Tumor) Profiling Business (2015-2020)
  • 13.10.5 Ribomed Biotechnologies Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer